Two common drugs could reverse fatty liver disease

Metabolic dysfunction-associated steatotic liver disease is currently the most widespread liver disorder globally, affecting roughly one in three adults. It occurs when excess fat builds up inside liver cells, leading to serious liver damage and a higher risk of death from cardiovascular disease. Researchers at the University of Barcelona have now found a promising approach […]